Earnings Scheduled For August 10, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
ADMA Biologics: Earnings Outlook
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Analysts estimate that ADMA Biologics will report an earnings per share (EPS) of $-0.08.
Why ADMA Biologics Shares Are Rising Today
ADMA Biologics Inc (NASDAQ: ADMA) shares are trading higher Monday after the company announced it received U.S. Food and Drug Administration approval for its sixth plasma collection center.
ADMA BioCenters Received FDA Approval for Sixth Plasma Collection Center, Located in Myrtle Beach, SC
ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it has received U.S.
Looking Into ADMA Biologics’s Return On Capital Employed
Benzinga Pro data, ADMA Biologics (NASDAQ:ADMA) reported Q1 sales of $29.10 million. Earnings fell to a loss of $25.01 million, resulting in a 50.2% decrease from last quarter.
ADMA Biologics Granted U.S. Patent #11,339,206 Compositions and methods for the treatment of immunodeficiency
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5426&f=G&l=50&d=PTXT&p=109&S1=20220524&OS=20220524&RS=20220524
Recap: ADMA Biologics Q1 Earnings
ADMA Biologics (NASDAQ:ADMA) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
ADMA Biologics missed estimated earnings by 25.0%, reporting an EPS of $-0.1 versus an estimate of $-0.08.
UPDATE: ADMA Biologics Q1 Adj EPS $(0.10) Misses $(0.08) Estimate, Sales $29.10M Beat $27.69M Estimate
ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 25 percent. This is a 37.5 percent increase over losses of $(0.16) per share from the
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell
• Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Earnings Outlook For ADMA Biologics
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement.
Analysts estimate that ADMA Biologics will report an earnings per share (EPS) of $-0.08.